Cargando…
Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use
Tenofovir was licensed for use in patients with HIV in 2001 and since then has become a firmly established anti-retroviral in both guidelines and routine practice. Data have been presented from many pivotal studies—informing on its efficacy, use, and adverse features—and there are also over 7.5 mill...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471058/ https://www.ncbi.nlm.nih.gov/pubmed/26032649 http://dx.doi.org/10.1007/s40121-015-0070-1 |